This medicine is available in a pen form and is injected subcutaneously (under the skin)
Bimagrumab is a first-in-class, fully humanized monoclonal antibody developed by Versanis Bio, a clinical-stage biopharmaceutical company recently acquired by Eli Lilly
Anil Chuturgoon, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Its primary actions include: Inhibiting the reuptake of dopamine and noradrenaline in the central nervous system Minimal effect on serotonin pathways, distinguishing it from most other antidepressants Potential appetite suppression as a secondary effect, though this is not its primary indication Reducing nicotine cravings through dopaminergic pathways Bupropion is metabolised primarily in the liver by the CYP2B6 enzyme system, producing active metabolites
Over-the-counter There is no approved over-the-counter weight loss drug in Canada
While traditionally employed to estimate hepatic fibrotic burden, elevated NFS and FIB-4 scores have also been independently associated with increased cardiovascular morbidity and mortality, suggesting their broader systemic relevance 77